AcuSurgical appoints Ronen Castro as CEO and Didier Deltort as Chairman, marking a new chapter in its mission to transform vitreoretinal surgery with robotics. Ronen brings 20+ years in medtech leadership, while Didier offers deep expertise in global healthcare. Founder Christoph Spuhler continues to lead innovation as the company prepares for its next phase of growth.

AcuSurgical has completed its first clinical study using the Luca™ surgical robot for vitrectomy, achieving 10-micron precision. Conducted at Ghent University Hospital by Dr. Fanny Nerinckx, seven successful surgeries confirmed the system's safety and efficiency. This milestone marks a major step toward expanding access to precise, robot-assisted retinal surgery worldwide.

AcuSurgical successfully completed its first robotic retinal surgery at Ghent University Hospital with Dr. Fanny Nerinckx. Using the Luca™ platform, the procedure demonstrated enhanced precision and control, paving the way for new treatments in retinal disease.

AcuSurgical raised €6M in Series A funding to support clinical trials and CE certification of its robotic system for retinal surgery. Designed with leading surgeons and robotics experts, the platform enhances precision and safety for conditions like AMD. Backed by top investors, AcuSurgical aims to expand treatment options for millions affected by retinal diseases.